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Distinct structural forms of type I collagen modulate cell cycle In the normal kidney, proliferation of resident glomer-
regulatory proteins in mesangial cells. ular cells is tightly regulated with a growth rate of less
Background. Extracellular matrix molecules profoundly reg- than 1% [1]. An imbalance in the control of glomerularulate cell behavior, including proliferation. In glomerulonephri-
mesangial cell (MC) proliferation leading to mesangialtis, type I collagen accumulates in the mesangium and is con-
hyperplasia is a prominent histopathological finding instantly structurally modified and degraded during the course
of the disease. many forms of glomerulonephritis, including IgA ne-
Methods. We studied how two structurally distinct forms of phropathy, membranoproliferative glomerulonephritis,
type I collagen, monomer versus polymerized fibrils, affect cell postinfectious endocapillary proliferative glomerulone-proliferation, mitogen-activated protein kinase (MAPK) activa-
phritis, and lupus nephritis. Persistent MC hyperplasiation, and expression of G1-phase regulatory proteins in cultured
appears to be pathogenetically linked to progressive glo-rat mesangial cells (MCs). To analyze the possible involvement
of collagen-binding integrins in type I collagen-derived growth merular scarring: In experimental models of glomerulo-
signals further, distribution patterns of integrin chains were pathy, MC proliferation frequently precedes and is linked
examined by immunocytochemistry. to the increase of extracellular matrix (ECM) in theResults. Polymerized type I collagen completely prevented
mesangium and glomerulosclerosis [2, 3]. Whether andthe increase of DNA synthesis and cell replication induced by
5% fetal calf serum (FCS) or 25 ng/mL platelet-derived growth how the accumulating ECM components affect MC
factor (PDGF) in MCs on monomer type I collagen. Protein growth behavior are presently uncertain.
expression of cyclins D1 and E was markedly down-regulated Over the past decade, numerous peptide factors havein MCs plated on polymerized type I collagen for eight hours
been identified that regulate MC proliferation. Many ofin 5% FCS, as compared with MCs on monomer type I collagen.
these soluble peptides possess autocrine growth-modu-Incubation with 5% FCS reduced expression of the cdk-inhibi-
tor protein p27Kip1 on monomer but not on polymerized type I lating activities, such as platelet-derived growth factor
collagen. Moreover, polymerized type I collagen markedly re- (PDGF), which is a strong MC mitogen in culture [4]
duced cyclin E-associated kinase activity in the presence of and in vivo [5, 6]. However, the presence of a soluble5% FCS. Polymerized type I collagen diminished the PDGF-
mitogen and its receptor is not necessarily sufficient toinduced phosphorylation and nuclear translocation of p42/p44
MAPK, but did not affect phosphorylation of PDGF b-recep- induce MC proliferation. The local ECM represents a
tors. In MCs plated on monomer type I collagen, a1, a2, and very heterogenous source of molecular information,
b1 integrin chains were recruited into focal contacts. However, which can profoundly regulate cell behavior, includingon polymerized type I collagen, a2 and b1, but not a1, integrin cell cycle progression. Several studies have explored thechains were condensed into focal contacts.
molecular basis of adhesion-dependent cell growth onConclusions. The growth-inhibitory effect of polymerized
type I collagen is characterized by rapid changes of expression the level of cell cycle regulators and indicated the com-
and/or activation of MAPK and G1-phase regulators and could bined requirement of both growth factors and ECM for
result from the lack of a1b1 integrin signaling in MCs on poly- anchorage-dependent cell growth of cells, which are inmerized type I collagen. Conceivably, deposition of polymer-
transit through the G1 phase and entry into S phase. Inized type I collagen might reflect a reparative response to
control MC replication in glomerular inflammation. fibroblasts, cell adhesion activates the cyclin E/cyclin-
dependent kinase 2 (cdk2) complex [7] and induces
cyclin D1 mRNA and phosphorylation of pRb, an effectKey words: glomerulonephritis, monomer fibrils, polymerized fibrils,
cell development, inflammation, hyperplasia, extracellular matrix, MAPK. that is possibly mediated by down-regulation of the nu-
clear cdk inhibitor proteins (CKI) p21Waf-1 and p27Kip1 [8].Received for publication September 10, 1999
In addition to the need of mere cell anchorage for prolif-and in revised form March 22, 2000
Accepted for publication March 27, 2000 eration, the pattern of expressed and/or activated adhe-
sion molecules may also influence cell cycle progression.Ó 2000 by the International Society of Nephrology
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Work by Mainiero et al in various cell types has indicated CO2 humidified atmosphere at 378C. MCs were used for
experiments between passages 5 and 20. Before mito-a direct growth-promoting function of integrin-depen-
dent shc signaling in anchorage-dependent growth [9]. genic stimulation, MC quiescence was achieved by incu-
bation for 72 hours in DMEM supplemented with 0.4%While most integrins are capable of activating focal adhe-
sion kinase upon attachment to ECM, a1b1, a5b1, avb3, heat-inactivated FCS, 50 U/mL penicillin, 50 mg/mL
streptomycin, 2 mmol/L glutamin, and 5 mg/mL insulin.and a6b4 integrins are coupled to the ras-ERK pathway
via recruitment of the adaptor protein, shc [9–11]. How- Quiescent MCs were then replated onto monomer or
polymerized type I collagen matrices or on cell cultureever, the precise nuclear signaling events that mediate
these ECM effects to control quiescence or proliferation plastic in DMEM supplemented with 0.4% heat-inacti-
vated FCS, 50 U/mL penicillin, 50 mg/mL streptomycin,of MCs remain to be clarified.
Under normal conditions, mesangial ECM compounds 2 mmol/L glutamin, and 5 mg/mL insulin. Growth factors
were added 12 hours after MCs were plated onto theare synthesized and degraded in a balanced manner,
since the integrity of glomerular matrices is strictly main- collagen preparations. PDGF-BB was purchased from
Boehringer (Mannheim, Germany) and was incubatedtained throughout adult life [12, 13]. A loss of coordinated
regulation with an altered composition and an increase at 25 ng/mL.
of mesangial ECM deposition occurs in virtually all forms
Collagen matricesof acute or chronic inflammatory glomerular disease. In
glomerulosclerosis, type I collagen is synthesized de novo Mesangial cells were cultured on the surface of colla-
gen preparations. Polymerized collagen fibrils (1 mg/mLand accumulates in the mesangium [14, 15]. Type I colla-
gen is also a prominent ECM molecule secreted by prolif- final concentration) were prepared by neutralizing the
acidic collagen solution (Vitrogen 100; Celtrix Labora-erating MCs in vitro [16, 17]. Several studies have indi-
cated that in addition to soluble regulator molecules, tories, Santa Clara, CA, USA) with 1/10 volume of 10 3
DMEM concentrate, adjusting the pH to 7.4 with 1 mol/Lnonsoluble ECM compounds can also influence MC
growth. In vitro, MCs show greater replication activity on NaOH and diluting to a final volume with 1 3 DMEM,
to which FCS was added to a final concentration of 0.4%.collagen IV, fibronectin, and thrombospondin [18, 19],
while heparan sulfate inhibits MC proliferation dose de- Gels formed after incubation of this solution (0.15 mL/cm2)
at 378C for 30 minutes. To coat with monomer collagenpendently [20, 21]. In addition, attachment to type I
collagen gels was shown to inhibit serum-induced prolif- (Vitrogen 100), culture dishes were soaked in 0.5% acetic
acid for 20 minutes at 608C, rinsed with dH2O, incubatederation of quiescent MCs while enhancing their endo-
thelin-mediated contractility [22]. with 1 mg/mL of collagen solution in 0.1 mol/L acetic acid
overnight, and then washed three times with DMEM.In the turnover of ECM during glomerulonephritis,
type I collagen is constantly degraded and structurally
Determination of 3H-thymidine uptake and ofmodified, for example, by proteolytic enzymes [23, 24].
MC replicationStimulated by work performed in vascular smooth mus-
cle cells (SMCs) [25], we tested the hypothesis that struc- Mesangial cells were growth arrested by culture in
medium supplemented with 0.4% FCS for 72 hours; 1.5 3turally distinct forms of type I collagen regulate MC
proliferation by differentially modulating the cell cycle 104 MCs per well were seeded using 96-well plates coated
with monomer or polymerized collagen preparations inregulatory proteins of MCs. As an in vitro system to
study the effects of structurally altered ECM molecules, medium supplemented with 0.4% FCS. After 12 hours,
quiescent MCs were stimulated with PDGF-BB (25 ng/mL)we examined how two structurally distinct forms of type I
collagen, monomer versus polymerized fibrils, affect pro- or 5% FCS and pulsed with 1 mCi/mL [3H-methyl]-thymi-
dine (specific activity, 5 mCi/mmol; Amersham Pharmacialiferation and expression of G1-phase regulators in MCs,
using two-dimensional cell culture. Biotech Europe, Freiburg, Germany). Twenty-four hours
after mitogenic stimulation, MCs were washed twice with
phosphate-buffered saline (PBS), lyzed with dH2O, andMETHODS
harvested onto filter paper using an automated cell har-
Cell culture vester (Bibby Dunn, Asbach, Germany). Incorporated
counts were measured in a liquid scintillation counterGlomeruli from kidneys of male Sprague-Dawley rats
(200 g) were isolated, and glomerular outgrowth and (Beckman, Mu¨nchen, Germany). To assess cell numbers,
5 3 104 quiescent MCs/well were seeded onto 24-wellsubsequent subculturing of MCs were performed as de-
scribed previously [26]. MCs were kept in Dulbecco’s plates coated with monomer or polymerized collagen
preparations in medium supplemented with 0.4% FCS.modified Eagle’s medium (DMEM) supplemented with
10% heat inactivated (508C, 30 minutes) fetal calf serum Mitogenic stimulation of MCs was performed as for
3H-thymidine uptake. Cell numbers were determined 48(FCS), 50 U/mL penicillin, 50 mg/mL streptomycin, 2
mmol/L glutamin, and 5 mg/mL insulin in a 95% air/5% hours after the addition of mitogens. Monolayers were
Scho¨cklmann et al: Type I collagen and cell cycle progression1110
washed twice in PBS. MCs were trypsinized and trans- Protein extraction and Western blot analysis
ferred into 10 mL of Isoton for counting in a coulter Subconfluent, quiescent MCs grown in 10 cm dishes
counter (Coulter Electronics, Krefeld, Germany). For coated with monomer or polymerized collagen prepara-
each value, three wells were counted twice. tions were harvested after stimulation with indicated
growth factors at the indicated time points in 100 mLFlow cytometric analysis
RIPA solution [50 mmol/L Tris-HCl, pH 7.2, 10 mmol/L
For flow cytometric analysis of DNA content, 4 3 105 EDTA, pH 7.2, 0.1% sodium dodecyl sulfate (SDS),
growth-arrested MCs were seeded into 100 mm diameter 1% sodium deoxycholate, 1% Triton X-100, 0.6 mmol/L
dishes coated with monomer or polymerized collagen phenylmethylsulfonyl fluoride (PMSF), 100 U/mL Trasy-
preparations. After 12 hours, MCs were incubated with lol, 2 mg/mL leupeptin, and 100 mmol/L sodium ortho-
10% FCS. Twenty-four hours after mitogenic stimula- vanadate]. Protein concentration was determined using
tion, MCs were washed twice with PBS, harvested by a commercially available assay based on the Bradford
trypsinization, washed twice with PBS, and fixed in 70% dye binding procedure (BioRad, Hercules, CA, USA).
ethanol in PBS for 30 minutes on ice. After two washes Protein samples containing 20 mg total protein were de-
with PBS, MCs were incubated with RNAse A (2 mg/mL) natured by boiling for five minutes and separated on a
for 30 minutes at 378C, washed twice with PBS, resus- 10% denaturing SDS-polyacrylamide gel electrophoresis
pended in 250 mL PBS, and stained with 50 mg/mL pro- (SDS-PAGE). After electrophoresis, the gels were elec-
pidium iodide (Sigma, Deisenhofen, Germany). Five 3 troblotted onto NC membranes (BioRad), and the trans-
104 cells of each sample were analyzed with a Beckman fer was controlled by Ponceau-S staining. Blots were
Coulter Epics XL cytometer and the System II software incubated in PBS containing 0.1% Tween-20 and 5%
(Beckman Coulter, Krefeld, Germany). For detection of nonfat dry milk powder to block unspecific binding,
surface expression of a1 integrin, quiescent MCs were washed in PBS containing 0.1% Tween-20, and incubated
plated onto monomer or polymerized collagen prepara- with primary antibodies. Applied primary antibodies
tions and stimulated with 5% FCS. After 12 and 24 hours, were directed against cyclin E, 1:500; cdk 2, 1:500; cyclin
MCs were harvested by trypsinization, and 2 3 105 MCs
D1, 1:500; cdk 4, 1:500; p27Kip1, 1:1000; p21Waf-1, 1:500;
per sample were incubated with 1 mg of antibody against
PDGF b-receptor, 1:1000; phosphotyrosine, 1:1000 (Santa
a1 integrin (Pharmingen, San Diego, CA, USA) for 30
Cruz Biotechnology, Santa Cruz, CA, USA) and p42/minutes on ice. Next, MCs were washed twice in PBS/5%
p44 mitogen-activated protein kinase (MAPK), 1:1000FCS, incubated with 2 mg of FITC-conjugated mouse
(IC Chemikalien, Ismaning, Germany); phosphorylatedanti-rabbit IgG (Pharmingen) for 30 minutes on ice,
p42/p44 MAPK, 1:1000 (New England Biolabs, Beverly,washed twice in PBS/5% FCS, and finally analyzed with
MA, USA). Applied secondary antibodies were peroxi-a Beckman Coulter Epics XL cytometer and the System
dase-conjugated goat anti-rabbit IgG, 1:10000 (Dianova,II software (Beckman Coulter).
Hamburg, Germany) and peroxidase-conjugated goat
anti-mouse IgG, 1:10000 (Santa Cruz Biotechnology). ForCell adhesion assay
visualization, the ECL system (Amersham Pharmacia Bio-Eight 3 104 quiescent MCs were seeded into 24-well
tech) was used according to the manufacturer’s protocol.culture plates coated with type I collagen preparations
in 1 mL volume 5% FCS-DMEM per well. After incuba- Immunoprecipitation of PDGF b-receptor subunit
tion for 15, 30, and 60 minutes and 24 hours, the nonad-
Ten minutes after stimulation with 25 ng/mL PDGF-herent MCs in the culture medium were collected, and
BB, subconfluent, quiescent MCs grown in 6 cm dishesthe adherent MCs were washed with PBS and harvested
coated with monomer or polymerized collagen prepara-by trypsinization [0.025% trypsin/10 mmol/L ethylenedi-
tions were washed twice in ice-cold PBS (containing 2.5aminetetraacetic acid (EDTA), 5 minutes]. Both adher-
mmol/L sodium orthovanadate, 2.5 mmol/L NaF) and har-ent and nonadherent MCs were counted in a Coulter
vested in 100 mL immunoprecipitation buffer (50 mmol/Lcounter (Coulter Electronics, Krefeld, Germany). Values
Tris, pH 7.2, 150 mmol/L NaCl, 1% Triton X-100, 1%of percentages of attached MCs were determined by calcu-
sodium deoxycholate, 0.1% SDS, 10 mmol/L EDTA, 1lating the ratios of adherent and nonadherent MCs per
mmol/L PMSF, 200 mmol/L sodium orthovanadate, andwell. To control for arginine-glycine-aspartate (RGD)-
1 mmol/L NaF). After preclearing with 30 mL proteinmediated cell adhesion, MCs were incubated with integ-
A-sepharose (Amersham Pharmacia Biotech), proteinrin-inhibitory RGD-peptides (100 mmol/L): avb3-antago-
extracts (100 mg) were immunoprecipitated for 16 hoursnist, cyclo-RGDfV (Bachem, Heidelberg, Germany) [27];
at 48C with 0.5 mg of an antibody specific for the PDGFcontrol peptide, cyclo-RADfV (Bachem). As the control
b-receptor subunit (Santa Cruz Biotechnology). Next,matrix, purified vitronectin (40 mg/mL; Collaborative
50 mL protein A-sepharose beads were added to eachBiomedical Products, Bedford, MA, USA) was used for
coating. sample, incubated at 48C for 45 minutes, and sedimented
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by brief centrifugation. The immunoprecipitates were were covered with Tris-buffered mowiol, pH 8.6 (Hoechst,
Frankfurt, Germany). Microscopy was performed usingwashed four times with ice-cold immunoprecipitation
a Leitz Aristoplan microscope with a 570 nm emissionbuffer, and equal amounts of immunoprecipitates were
filter. MCs were photographed using Kodak T-MAXseparated in 7.5% SDS-polyacrylamide gels and electro-
film (3200 ASA; Eastman Kodak, Rochester, NY, USA).phoretically transferred to nitrocellulose filters. Phos-
Controls with inappropriate secondary or primary anti-phorylated PDGF b-receptor subunit was detected by
bodies did not exhibit significant unspecific immunostain-Western blot analysis using an antibody directed against
ing. Applied primary antibodies were directed against: a1phosphotyrosine residues (1:1000; Santa Cruz Biotech-
integrin, 1:100 (Pharmingen); a2 integrin, 1:100 (Phar-nology). To assess amounts of loaded PDGF b-receptor
mingen); b1 integrin, 1:100 (Pharmingen); vinculin, 1:500protein, filters were stripped with 2% SDS, 100 mmol/L
(Sigma); and p42/p44 MAPK 1:100 (New England Bio-b-mercaptoethanol in 62.5 mmol/L Tris-HCl, pH 6.8, for
labs, Beverly, MA, USA). Applied secondary antibodies30 minutes at 708C, and reprobed for PDGF b-receptor,
were Cy2-labeled goat anti-mouse (Dianova), Cy3-labeledas described previously in this article.
goat anti-rabbit, and FITC-conjugated mouse anti-hamster
IgG (Pharmingen).Cyclin E-associated histone H1 kinase activity
Whole-cell protein extracts were prepared by lysis in Statistical analysis
HEPES-buffer (50 mmol/L HEPES, pH 7.0, 150 mmol/L
For statistical analysis, two-way analysis of variance,NaCl, 0.1% NP-40, 0.2 mmol/L PMSF, 100 mmol/L so-
followed by post hoc Scheffe´ test, was used. Values ofdium orthovanadate, 10 mmol/L b-glycerophosphate, 1
P , 0.05 were considered significant. The proceduresmmol/L NaF, and 0.33 TIU/mL aprotinin). After pre-
were carried out using the SPSS software (SPSS, Chi-clearing with 40 mL protein A-agarose, protein extracts
cago, IL, USA). Values are displayed as means 6 SD.(500 mg) were immunoprecipitated for one hour at 48C
with an antibody specific for cyclin E (Santa Cruz Bio-
technology), which is associated with active cdk2. Cdk2- RESULTS
associated kinase activity in the immunoprecipitates was Adhesion and spreading of MCs are similarly
determined using histone H1 as substrate. For assay of effective on monomer and polymerized type I
cdk2 kinase activity, immune complexes of cyclin E/cdk2 collagen matrices
were resuspended in 35 mL kinase buffer containing 0.26
Our working hypothesis proposed that structurally dis-mg/mL histone H1 (Sigma), 1 mmol/L cold adenosine
tinct forms of type I collagen regulate MC proliferation
59-triphosphate (ATP), 0.5 mCi/mL [g-32P]ATP (Amer-
by modulating cell cycle regulatory proteins of MCs. To
sham Pharmacia Biotech), 50 mmol/L Tris/HCl, pH 7.4, investigate how the structure of type I collagen affects
10 mmol/L MgCl2, and 1 mmol/L DTT. After incubation MC proliferation, we prepared two distinct forms of
for 30 minutes at 308C, reactions were terminated by type I collagen: monomer (coated on plastic in acetic
heating at 958C for 10 minutes. Phosphorylated products acid) and polymerized fibrils (formed as a thin gel by
were analyzed on a 10% SDS-PAGE and visualized by neutralizing the acidic collagen solution). Initial studies
autoradiography. Exposure time was about one hour. were performed to obtain information on the efficiencies
of adhesion and spreading of MCs onto the collagenImmunocytochemistry
matrices. Freshly seeded MCs adhered equally effective
For immunocytochemical staining for focal contact to monomer and polymerized type I collagen, as com-
components, integrins and MAPK, glass 8-well chamber pared with MCs plated on cell culture plastic. While
slides were coated with specified monomer or polymer- overall adhesion of MCs increased over time after seed-
ized type I collagen preparations and were blocked with ing, there were no significant differences of percentages
2% denatured BSA. After washing with PBS, MCs of attached cells between the three matrix conditions
(40,000 cells/well) were seeded in 0.4% FCS-DMEM. (Fig. 1A). To examine the degree of spreading of MCs
After a four-hour incubation period, the medium was seeded onto monomer and polymerized type I collagen,
removed. Adherent cells were rinsed in PBS and fixed in sequential photomicrographs were taken. After two
paraformaldehyde (3%, 20 minutes, 48C). Free aldehyde hours, MCs plated onto polymerized type I collagen dis-
groups were blocked with ammonium chloride (50 played a more rounded phenotype as compared with
mmol/L in PBS, 20 minutes, 48C), and nonspecific bind- MCs plated on monomer collagen, indicating slower ini-
ing was blocked by FCS (20 minutes, 208C). Slides were tial spreading of MCs on polymerized type I collagen.
incubated overnight with the respective primary antibod- However, at four hours after seeding, no differences
ies (diluted in 1% FCS in PBS, 48C). After washing with in the degree of cellular spreading could be detected
PBS, the secondary antibody (diluted in 1% FCS in PBS, between cells plated on the two collagen preparations
(data not shown).208C) was added for two hours. After washing, the slides
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Fig. 1. Polymerized type I collagen suppresses mesangial cell (MC) proliferation induced by serum or platelet-derived growth factor (PDGF).
(A) Adhesion of MCs on monomer and polymerized type I collagen matrices. Quiescent MCs were seeded onto monomer (h) or polymerized
(j) type I collagen (Col I) or on cell culture plastic (control; ) in 5% FCS-DMEM. After indicated time periods, both adherent and nonadherent
MCs were collected, and percentages of attached MCs were determined. Values are from four samples. (B) Growth-arrested MCs were seeded
on monomer (h) or polymerized (j) type I collagen (Col I) or on plastic (control; ) and stimulated with 5% FCS. 3H-thymidine uptake was
determined 24 hours after stimulation. Values are from five samples. (C) Quiescent MCs were seeded on monomer (h) or polymerized (j) Col
I or on plastic (control; ) and were stimulated with 5% FCS. Cell counts were determined 48 hours after stimulation (N 5 4). (D) Growth-
arrested MCs were plated on monomer (h) or polymerized (j) Col I or on plastic (control; ) and stimulated with 25 ng/mL PDGF. 3H-thymidine
uptake was determined 24 hours after stimulation (N 5 5). Significances were calculated comparing unstimulated MCs plated on cell culture plastic
to MCs plated on collagen matrices or to mitogen-stimulated MCs, respectively. All data are means 6 SD; * P , 0.05.
Polymerized type I collagen suppresses 1B). This antimitogenic effect of polymerized type I col-
mitogen-induced DNA synthesis and MC replication lagen was maintained for up to 72 hours in the presence
and blocks the G1/S-phase transition of of FCS (data not shown), indicating that MCs remained
serum-stimulated MCs growth arrested on polymerized type I collagen and that
entry into the cell cycle was not merely delayed. Forty-To investigate how the two structurally distinct type I
eight hours after mitogenic stimulation of MCs with 5%collagen matrices affect MC proliferation, we examined
FCS, MC numbers were increased 2.5-fold on monomerthe effects of each on PDGF- and FCS-stimulated MC
type I collagen (plastic control, 2.6-fold) in contrast toproliferation. Polymerized type I collagen completely pre-
polymerized type I collagen (1.0-fold; Fig. 1C). Similarvented the increase of DNA synthesis and MC replica-
growth-inhibitory effects of polymerized type I collagention stimulated by FCS. Twenty-four hours after mito-
were observed when MCs were stimulated with PDGF.genic stimulation of growth-arrested MCs with 5% FCS,
Twenty-four hours after mitogenic stimulation of growth-3H-thymidine incorporation was increased 6.6-fold on
arrested MCs with 25 ng/mL PDGF, the increase ofmonomer type I collagen (plastic control, 5.9-fold) in
contrast to polymerized type I collagen (0.8-fold; Fig. 3H-thymidine incorporation detected in MCs plated on
Scho¨cklmann et al: Type I collagen and cell cycle progression 1113
Fig. 2. Polymerized type I collagen mediates
suppression of protein expression of G1-phase
cyclins. Growth-arrested MCs were seeded
onto monomer or polymerized type I collagen
(Col I) matrices or onto plastic (control) and
were stimulated with 5% FCS. MCs were har-
vested, and protein was extracted eight hours
after stimulation. Twenty micrograms of pro-
tein per lane were size fractionated by SDS-
PAGE, and protein expression of cyclins D1
and E, as well as of cdks 2 and 4, was deter-
mined by Western blot. The data depicted are
from one representative out of three experi-
ments.
monomer type I collagen or on cell culture plastic was ized collagen affects expression of the G1-phase regula-
completely inhibited in MCs plated on polymerized tory proteins in MCs. The protein abundance of cyclins
type I collagen (Fig. 1D). Under quiescent conditions, D1, E, and cdks 2 and 4 was determined by Western
no differences in DNA synthesis or MC replication were blot eight hours after mitogenic stimulation. This time
observed between the two type I collagen preparations point corresponds to the mid to late G1 phase in MCs,
(Fig. 1 B–D). The growth-inhibitory effect of polymerized as determined by our previous studies [28]. Expression
type I collagen was reversible, since MCs responded to of G1-phase cyclins E and D1 was markedly suppressed
mitogenic stimuli and replicated when trypsinized from in MCs on polymerized type I collagen even under quies-
polymerized type I collagen and replated onto monomer cent conditions, as compared with MCs plated on mono-
type I collagen or plastic (data not shown). Also, the mer collagen or plastic. After stimulation with 5% FCS,
inhibition of MC proliferation by polymerized type I expression of cyclin E remained low in MCs plated on
collagen was not dependent on the collagen concentra- polymerized type I collagen, while expression of cyclin
tion, because concentrations of 0.1 to 3.0 mg/mL were D1, the major cyclin D species in MCs [29], increased.
equally effective (data not shown). Cell cycle analysis of The FCS-induced increase of cyclins D1 and E was clearly
MCs on polymerized type I collagen revealed that 24 higher, both on monomer type I collagen and in plastic,
hours after stimulation with 10% FCS, only 1.9% of MCs
than in MCs plated on polymerized type I collagen (Fig.were in the S-phase fraction, 8.0% in G2/M-phase, and 2). In contrast, protein expression of the G1-phase cdks90.1% of MCs were arrested in G0/G1-phase. In contrast, 2 and 4 was not affected by the underlying matrix (Fig. 2).on monomer type I collagen, 60.5% of MCs were in the
Next, we asked whether the marked reduction of cyclin EG0/G1-phase, 19.4% in S-phase, and 20.1% in G2/M-phase
expression results in decreased activation of the cyclin24 hours after mitogenic stimulation with 10% FCS.
E/cdk2 complex. Active cyclin E/cdk2 complexes are
Polymerized type I collagen suppresses protein required for progression of cells from G1 into S phase.
expression of G1-phase cyclins and prevents the As depicted in Figure 3, 5% FCS induced cyclin E-associ-
serum-induced increase of cyclin E-associated ated histone H1 kinase activity in quiescent MCs at four
histone H1 kinase activity hours and, more prominently, after eight hours of stimu-
lation in MCs plated on monomer type I collagen. InSince polymerized type I collagen induced cell cycle
arrest in the G1 phase, we examined whether polymer- contrast, cyclin E-associated histone H1 kinase activity
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Therefore, we next asked whether the growth-modula-
tory effects of structurally distinct forms of type I colla-
gen are reflected on the level of MAPK phosphorylation,
which correlates with its activity. Stimulation of quies-
cent MCs with 25 ng/mL PDGF for 10 minutes led to a
marked increase of p42/p44 MAPK phosphorylation in
MCs plated on monomer type I collagen or plastic (Fig.
5). However, in MCs plated on polymerized type I colla-
gen, PDGF-induced p42/p44 MAPK phosphorylation
was clearly diminished (Fig. 5). Since phosphorylation
of p42/p44 MAPK has been reported to promote its
nuclear translocation [31, 32], we examined the effects
of the two type I collagen preparations on intracellular
distribution patterns of p42/p44 MAPK. Mitogenic stim-
ulation of MCs with 25 ng/mL PDGF for four hours led
to a pronounced nuclear translocation of p42/p44 MAPK
Fig. 3. Polymerized type I collagen inhibits mitogen-induced cyclin
in most MCs (.90%) plated on monomer type I colla-E-associated histone H1 kinase activity. Growth-arrested MCs were
seeded onto monomer or polymerized type I collagen matrices and gen. In contrast, MCs on polymerized type I collagen
were incubated with 5% FCS. After four and eight hours of incubation, displayed a diffuse cytoplasmic distribution pattern after
whole-cell extracts were prepared and immunoprecipitated with an
stimulation with PDGF (Fig. 6). Taken together, theseanticyclin E antibody. Kinase activities of cyclin E/cdk2 complexes in
the immunoprecipitates were determined by phosphorylation of histone results indicate that polymerized type I collagen may
H1. Phosphorylated histone H1 substrate protein was analyzed by auto- have interfered with the PDGF-induced signaling path-
radiography (upper panel), and coimmunoprecepitated cdk2 protein
way at or above the level of MAPK activation.was visualized by Western blot analysis (lower panel).
Platelet-derived growth factor-induced tyrosine
phosphorylation of PDGF b-receptor subunits
was inhibited in MCs on polymerized type I collagen. is not affected by polymerized type I collagen
The amounts of coimmunoprecipitated cdk2 protein at
To determine whether polymerized type I collageneach time point were equal, as assessed by Western blot
affects the PDGF-mediated mitogenic signaling cascadeanalysis (Fig. 3).
at the level of PDGF receptor activation, we examined the
effects of the two type I collagen preparations on PDGFPolymerized type I collagen prevents the
b-receptor tyrosine phosphorylation. Stimulation of quies-serum-induced suppression of p27Kip1
cent MCs with 25 ng/mL PDGF for 10 minutes led to aTo investigate other mechanisms besides cyclin E sup-
pronounced tyrosine phosphorylation of PDGF b-recep-pression further, how polymerized type I collagen may
tors on all tested matrix conditions (Fig. 7). The amountslead to a reduction of cyclin E/cdk2 activity, we examined
of immunoprecipitated PDGF b-receptor protein werethe regulation of two candidates for cdk2 inhibition, the
equal, as assessed by Western blot analysis (Fig. 7).CKIs p21Waf-1 and p27Kip1 in MCs [30]. Western blot analy-
sis of p27Kip1 revealed similar expression levels in MCs Mesangial cells plated on monomer but not on
plated on monomer and polymerized type I collagen or polymerized type I collagen recruit a1 integrinon plastic. Stimulation with 5% FCS for eight hours led chains into focal contacts
to a reduction of p27Kip1 protein levels in MCs plated on
To determine whether the growth-modulatory effectsmonomer type I collagen or plastic, that is, in conditions
of monomer and polymerized type I collagen are associ-that permit FCS-induced MC replication. However, in
ated with differential expression and/or distribution pat-MCs seeded onto polymerized type I collagen, serum-
terns of collagen-binding integrins, we examined the re-induced suppression of p27Kip1 was clearly diminished
cruitment of integrin chains into focal contacts by(Fig. 4). In contrast to the regulation of p27Kip1, protein
immunocytochemistry. a1b1 and a2b1 integrins are theexpression of the CKI p21Waf-1 remained rather unaffected
major type I collagen-binding integrins expressed byby the substratum or addition of FCS, as assessed by
MCs [33, 34]. Staining for vinculin, a component of focalWestern blot analysis (Fig. 4).
contacts, served as a control and revealed an equal num-
Platelet-derived growth factor-induced phosphorylation ber and density of focal contact formation in MCs plated
and nuclear translocation of p42/p44 MAPK are on monomer and polymerized type I collagen (Fig. 8).
inhibited in MCs plated on polymerized type I collagen In MCs plated on monomer type I collagen, a1, a2, and
b1 integrin chains were recruited into focal contacts.Numerous mitogenic signaling pathways, including
PDGF-elicited signals, lead to the activation of MAPK. However, on polymerized type I collagen, a2 and b1,
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Fig. 4. Polymerized type I collagen prevents
the serum-induced suppression of p27Kip1. Qui-
escent MCs were seeded onto monomer or
polymerized type I collagen or onto plastic
(control) and were stimulated with 5% FCS.
Eight hours after serum stimulation, MCs
were harvested. and protein was extracted.
Twenty micrograms of protein per lane were
size fractionated by SDS-PAGE, and protein
expression of the cdk-inhibitors p27Kip1 and
p21Waf1 was determined by Western blot. The
data are from one representative out of two
experiments.
76.9% (12 hours) and 73.5% (24 hours) of MCs ex-
pressed a1 integrins, indicating decreased surface expres-
sion of a1 integrin chains on polymerized as compared
with monomer type I collagen (one out of three experi-
ments with similar results).
Since avb3 integrin has also been described as a colla-
gen receptor in other cell types [35], we further tested
the involvement of avb3 integrin-mediated signals in the
observed growth-regulatory effects of type I collagen by
incubation with avb3-inhibitory RGD peptides. Incuba-
tion of 100 mmol/L avb3-inhibitory cyclo-RGDfV [27] for
24 hours did not influence the proliferative responses of
MCs plated on monomer or polymerized type I collagen
and stimulated with 5% FCS, compared with MCs incu-
Fig. 5. Platelet-derived growth factor (PDGF)-induced phosphoryla- bated with 100 mmol/L cyclo-RGDfV control peptide,tion of p42/p44 mitogen-activated protein kinase (MAPK) is inhibited in
as determined by 3H-thymidine-incorporation (cyclo-mesangial cells (MCs) plated on polymerized type I collagen. Quiescent
MCs were seeded onto monomer or polymerized type I collagen or RGDfV: monomer type I collagen, 13,670 6 1769 cpm;
onto plastic (control) and were stimulated with 25 ng/mL PDGF. Ten polymerized type I collagen, 2368 6 360 cpm; controlminutes after mitogenic stimulation, MCs were harvested, and protein
peptide: monomer type I collagen, 14226 6 1208 cpm;was extracted. Twenty micrograms of protein per lane were size fraction-
ated by SDS-PAGE, and abundances of phosphorylated p44/p42 MAPK polymerized type I collagen, 2659 6 571 cpm; N 5 5).
(upper panel) and of total p44/p42 MAPK protein (lower panel) were
Incubation of FCS-stimulated MCs with 100 mmol/Ldetermined by Western blot analysis.
avb3-inhibitory cyclo-RGDfV for 24 hours did not affect
adhesion of MCs to monomer or polymerized type I
collagen, but markedly reduced the adhesion of MCs
but not a1, integrin chains were condensed into focal to vitronectin (data not shown). Taken together, these
contacts, indicating activation of a1b1 integrins on mono- results argue against the contribution of avb3 integrins
mer but not on polymerized type I collagen (Fig. 8). to the proliferative response of MCs to soluble mitogens
Furthermore, we examined the possibility that polymer- observed on monomer type I collagen.
ized type I collagen influences cell surface expression of
a1 integrin chains. For this purpose, quiescent MCs were
DISCUSSIONplated onto monomer or polymerized collagen prepara-
In inflammatory glomerular disease, glomerular hyper-tions and stimulated with 5% FCS, and expression of a1
cellularity caused by MC proliferation has been associ-integrins was analyzed after 12 and 24 hours by flow-
ated with the development of glomerulosclerosis andcytometric analysis. On monomer type I collagen, 91.0%
progressive loss of renal function [2, 3]. The concept(12 hours) and 96.4% (24 hours) of MCs expressed a1
integrins. However, on polymerized type I collagen, has been advanced that ongoing MC replication also
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Fig. 6. PDGF-mediated nuclear translocation of p42/p44 MAPK is inhibited in MCs plated on polymerized type I collagen. Quiescent MCs were
seeded onto monomer or polymerized type I collagen and stimulated with 25 ng/mL PDGF. Four hours after mitogenic stimulation, MCs were
stained for p44/p42 MAPK and were photographed. Control, unstimulated MCs (magnification 3800).
activates the synthetic-secretory phenotype of MCs, reduces their mitogenic responsiveness and proliferation
[22, 37–39]. In contrast, monomer type I collagen waswhich contributes to mesangial ECM expansion and may
ultimately lead to glomerular scarring [30]. Compared shown to exert growth-promoting effects on vascular
SMCs and has been employed as a model system forwith the large amount of information available on solu-
ble factors involved in regulation of MC replication in structurally altered type I collagen [25].
Our hypothesis proposed that structurally distinctculture and in vivo, little is known about how compo-
nents of the mesangial ECM stimulate or inhibit MC forms of type I collagen regulate MC proliferation by
modulating cell cycle regulatory proteins of MCs. Thegrowth. While type I collagen is not found in the mesan-
gium of the normal mammalian kidney, glomerular de- present results indicate that polymerized type I collagen
but not the monomer form leads to a pronounced sup-position of type I collagen is greatly increased during
glomerulonephritis [14, 15]. In reversible glomerular in- pression of cyclin E and, although to a lesser degree, of
cyclin D1 in MCs. These observations are associated withflammation, the mesangial accumulation of type I colla-
gen is transient [14], indicating that type I collagen is inhibited mitogen-induced activation of cyclin E/cdk2
complexes and with a lack of mitogen-induced suppres-constantly degraded and structurally modified, for exam-
ple, by proteolytic action. The capacity of polymerized sion of the CKI p27Kip1. Several observations of type I
collagen-mediated signaling events in MCs were clearlytype I collagen to inhibit cell proliferation has been ap-
preciated for some time [36], and several studies in cul- different from those described in SMCs by Koyama et al
[25]. While polymerized type I collagen also suppressedtured MCs have shown that polymerized type I collagen
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Fig. 7. PDGF-induced tyrosine phosphoryla-
tion of PDGF b-receptor subunits is not af-
fected by polymerized type I collagen. Growth-
arrested MCs were seeded onto monomer or
polymerized type I collagen or onto plastic
(control) and were stimulated with 25 ng/mL
PDGF. Ten minutes after mitogenic stimula-
tion, whole-cell protein extracts were prepared
and immunoprecipitated with an antibody di-
rected against PDGF b-receptor. The upper
panel shows an immunoblot with antiphospho-
tyrosine antibody. In the lower panel, the blot
was reprobed with an anti-PDGF b-receptor
antibody after stripping. Blots shown are from
one representative of three experiments with
similar results.
mitogen-stimulated cyclin E-associated kinase activities, cules in two-dimensional culture systems is associated
with focal adhesion assembly and outside-in signaling bythe protein levels of cyclin E were not suppressed in
SMCs. Cyclin D1 protein was also slightly suppressed integrins [40, 41]. On the level of integrin expression and
distribution, we observed that on polymerized type Iin SMCs under basal conditions on polymerized type I
collagen. However, in SMCs, PDGF reportedly increased collagen, a2 and b1—but not a1—integrin chains were
condensed into focal contacts, while all three integrinthe level of cyclin D1 on polymerized collagen being com-
parable to that on monomer collagen [25]. In SMCs, both chains were recruited into focal contacts on monomer
type I collagen (Fig. 8). These results indicate that a1b1p21Waf-1 and p27Kip1 protein were up-regulated by poly-
merized type I collagen as compared with monomer type I integrins are activated on monomer but not on polymer-
ized type I collagen. In addition, the lack of recruitmentcollagen [25], while in MCs p21Waf-1 remained unchanged
by the underlying matrix. Clearly, the most dramatic of a1 integrin chains into focal contacts correlated with
the flow-cytometric data showing decreased surface ex-difference in terms of collagen-affected G1-phase regula-
tors in MCs as compared with SMCs is the marked down- pression of a1 integrin in MCs after attachment to poly-
merized type I collagen, as compared with MCs platedregulation of cyclin E by polymerized type I collagen.
We found that polymerized type I collagen diminished on monomer type I collagen. At present, the functional
relevance of these findings for the growth-permissivethe PDGF-induced p42/p44 MAPK phosphorylation and
nuclear translocation in MCs, indicating that polymer- effects of monomer type I collagen is not entirely clear. In
SMCs plated on monomer collagen, monovalent blockingized type I collagen may interfere with the PDGF-induced
signaling pathway at or above the level of MAPK activa- antibodies to a2 integrins induced up-regulation of p21Waf-1
and p27Kip1 protein and suppressed cyclin E-associatedtion. However, activation of PDGF b-receptors in MCs
was apparently not affected by polymerized type I colla- kinase activity, suggesting that a2b1 integrins are respon-
sible for the promitogenic effects of monomer type Igen, since the PDGF-mediated tyrosine phosphorylation
of PDGF b receptor subunits was not inhibited in MCs collagen [25]. However, our observations are in agree-
ment with several reports by Giancotti et al, who identi-plated on polymerized type I collagen.
In SMCs, p42/p44 activities showed no significant dif- fied a1b1 integrins and other integrins as capable to acti-
vate the ras-ERK pathway via recruitment of the adaptorferences after plating on monomer or polymerized type I
collagen [25]. However, our findings are in keeping with protein, shc. In endothelial cells and keratinocytes, liga-
tion of integrins linked to shc enabled cell cycle progres-a recent report by Miralem and Templeton, who demon-
strated that polymerized collagen prevents the activation sion in response to soluble mitogens. In contrast, ligation
of other integrins, such as a2b1 integrins, resulted inof p42 MAPK (Erk-2) induced by 5% serum in MCs, as
compared with MCs grown on plastic [39]. This effect growth arrest, even in the presence of soluble mitogens.
The results of these studies indicate a direct growth-correlated with a decreased induction of the proto-onco-
gene c-fos in MCs plated on polymerized collagen and promoting function of integrin-dependent shc signaling
in anchorage-dependent growth [9–11, 42–44]. The exis-stimulated with serum. In addition, activities of other
kinases were found to be suppressed, including Ca21/ tence and relevance of such regulatory mechanisms in
MCs are presently unknown. In addition to its mediationcalmodulin-dependent kinase and protein kinase C [39].
Conceivably, these effects of polymerized type I collagen of collagen-derived growth signals in nonrenal cell types
[42, 43], a1b1 integrin was also shown to be involved inon kinase activities may contribute to the induction of
a nonproliferative, quiescent MC phenotype. collagen matrix remodeling by MCs. A recent study by
Kagami et al reported that a1b1 integrin-mediated type IIntegrin-mediated attachment of cells to ECM mole-
Scho¨cklmann et al: Type I collagen and cell cycle progression1118
Fig. 8. a1-Integrin chains are recruited into focal contacts in MCs plated on monomer but not on polymerized type I collagen. MCs were allowed
to adhere to monomer or polymerized type I collagen for four hours in 0.4% FCS-DMEM. MCs were then stained for b1-, a1-, and a2-integrin
chains as well as for vinculin, which served as a marker protein for the formation of focal contacts, and were photographed (magnification 31200).
Focal contacts are marked with white arrowheads.
Scho¨cklmann et al: Type I collagen and cell cycle progression 1119
Schlessinger J, Giancotti FG: Signal transduction by the a6b4collagen gel contraction can be modulated by trans-
integrin: Distinct b4 subunit sites mediate recruitment of Shc/Grb2
forming growth factor-b and PDGF via different mecha- and association with the cytoskeleton of hemidesmosomes. EMBO
J 14:4470–4481, 1995nisms in cultured rat MCs [45].
10. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, GiancottiThe available evidence indicates that adhesion-depen-
FG: The adaptor protein Shc couples a class of integrins to the
dent signaling can provide localized cues from the ECM, control of cell cycle progression. Cell 87:733–743, 1996
11. Wary KK, Mariotti A, Zurzolo C, Giancotti FG: A requirementwhich may control the phenotypic changes of MCs, in-
for caveolin-1 and associated kinase Fyn in integrin signaling andcluding proliferation. Based on our findings, one may
anchorage-dependent cell growth. Cell 94:625–634, 1998
speculate that mesangial deposition of native, polymer- 12. Gauer S, Yao J, Schoecklmann HO, Sterzel RB: Adhesion mole-
cules in the glomerular mesangium. Kidney Int 51:1447–1453, 1997ized type I collagen in glomerular disease limits the pro-
13. Pro¨ls F, Hartner A, Schoecklmann HO, Sterzel RB: Mesangialliferative reaction of MCs to soluble mitogens and might
cells and their adhesive properties. Exp Nephrol 7:137–146, 1999
represent a reparative response to restore a more differ- 14. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura
A, Campbell C, Alpers CE, Couser WG: Increased synthesis ofentiated, quiescent MC phenotype. On the other hand,
extracellular matrix in mesangial proliferative nephritis. Kidneystructural alteration of type I collagen, for example, by
Int 40:477–488, 1991
proteolytic degradation, may permit persistent MC pro- 15. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser
WG, Johnson RJ: Glomerular cells, extracellular matrix accumula-liferation in concert with soluble growth factors. Con-
tion, and the development of glomerulosclerosis in the remnantceivably, the capacity of MCs to respond to mitogenic
kidney model. Lab Invest 66:485–497, 1992
stimuli is tightly regulated by topical changes in the 16. Ardaillou N, Bellon G, Nivez MP, Rakotoarison S, Ardaillou
R: Quantification of collagen synthesis by cultured human glomeru-ECM. Clearly, further studies are required to elucidate
lar cells. Biochim Biophys Acta 991:445–452, 1989the growth-regulatory effects of ECM molecules on MC
17. Ohyama K, Seyer JM, Raghow R, Kang AH: Extracellular matrix
proliferation in culture and in vivo. phenotype of rat mesangial cells in culture: Biosynthesis of collagen
types I III, IV, and V and a low molecular weight collagenous
component and their regulation by dexamethasone. J Lab ClinACKNOWLEDGMENT
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